JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RBNC
4901
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $55K | ﹤0.01% |
2,465
-115
| -4% | -$2.56K |
2017 Q4
5 quarters
|
|
4902
WisdomTree US SmallCap Earnings Fund
EES
$693M
| $54K | ﹤0.01% |
1,500
| – | – |
2018 Q4
1 quarter
|
|
|
KZR
4903
DELISTED
Kezar Life Sciences
KZR
| $54K | ﹤0.01% |
306
+174
| +132% | +$34.3K |
2018 Q3
2 quarters
|
|
4904
Omega Flex
OFLX
$262M
| $54K | ﹤0.01% |
710
-3,315
| -82% | -$227K |
2017 Q4
5 quarters
|
|
4905
TFS Financial
TFSL
$4.72B
| $54K | ﹤0.01% |
3,270
+220
| +7% | +$3.68K |
2017 Q4
5 quarters
|
|
4906
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.09B
| $54K | ﹤0.01% |
776
| – | – |
2017 Q4
5 quarters
|
|
4907
Cadiz
CDZI
$307M
| $53K | ﹤0.01% |
5,516
-259
| -4% | -$2.58K |
2017 Q4
5 quarters
|
|
4908
i3 Verticals
IIIV
$265M
| $53K | ﹤0.01% |
2,223
+251
| +13% | +$5.84K |
2018 Q3
2 quarters
|
|
4909
VanEck Pharmaceutical ETF
PPH
$1.02B
| $53K | ﹤0.01% |
880
-907
| -51% | -$53.6K |
2015 Q1
16 quarters
|
|
4910
SmartFinancial
SMBK
$872M
| $53K | ﹤0.01% |
2,809
-94
| -3% | -$1.8K |
2017 Q4
5 quarters
|
|
4911
Spyre Therapeutics
SYRE
$8.15B
| $53K | ﹤0.01% |
267
+99
| +59% | +$20.6K |
2017 Q2
7 quarters
|
|
|
NYMX
4912
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $53K | ﹤0.01% |
26,913
+1,098
| +4% | +$2.33K |
2017 Q4
5 quarters
|
|
4913
Coda Octopus Group
CODA
$124M
| $52K | ﹤0.01% |
+5,590
| New | +$41.1K |
2019 Q1
0 quarters
|
|
4914
Gold Fields
GFI
$31.7B
| $52K | ﹤0.01% |
13,933
-295,138
| -95% | -$1.14M |
2013 Q2
23 quarters
|
|
4915
Green Brick Partners
GRBK
$2.84B
| $52K | ﹤0.01% |
5,985
-281
| -4% | -$2.42K |
2017 Q4
5 quarters
|
|
4916
Kiniksa Pharmaceuticals
KNSA
$5.96B
| $52K | ﹤0.01% |
2,880
+1,222
| +74% | +$23.6K |
2018 Q3
2 quarters
|
|
4917
Arq
ARQ
$87.8M
| $52K | ﹤0.01% |
4,510
-211
| -4% | -$2.41K |
2017 Q2
7 quarters
|
|
|
ONIT
4918
Onity Group
ONIT
$231M
| $52K | ﹤0.01% |
1,912
-89
| -4% | -$2.5K |
2017 Q4
5 quarters
|
|
|
MLVF
4919
DELISTED
Malvern Bancorp, Inc.
MLVF
| $52K | ﹤0.01% |
2,564
-2,323
| -48% | -$47.7K |
2017 Q4
5 quarters
|
|
|
CNST
4920
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $52K | ﹤0.01% |
3,848
+1,779
| +86% | +$15.9K |
2018 Q3
2 quarters
|
|
|
ACB
4921
PUT
Aurora Cannabis
ACB
$286M
| $51K | ﹤0.01% |
+47
| New | +$42K |
2019 Q1
0 quarters
|
|
4922
Amerant Bancorp
AMTB
$1.15B
| $51K | ﹤0.01% |
+3,690
| New | +$52.9K |
2019 Q1
0 quarters
|
|
4923
Ardmore Shipping
ASC
$789M
| $51K | ﹤0.01% |
8,241
-383
| -4% | -$2.1K |
2017 Q3
6 quarters
|
|
4924
iShares MSCI BIC ETF
BKF
$67.3M
| $51K | ﹤0.01% |
1,187
| – | – |
2017 Q4
5 quarters
|
|
4925
Evolus
EOLS
$486M
| $51K | ﹤0.01% |
2,271
-107
| -4% | -$2.31K |
2018 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.